MCID: PRM020
MIFTS: 40

Premenstrual Tension

Categories: Mental diseases, Reproductive diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Premenstrual Tension

Summaries for Premenstrual Tension

PubMed Health : 63 Premenstrual syndrome: In the days leading up to their period, many women experience abdominal pain or a headache, are sad and irritable or feel bloated and generally uncomfortable. The medical term for this is “premenstrual syndrome” (PMS), also known as “premenstrual tension” (PMT). PMS symptoms are usually not very severe, and most women cope well with them. But in some women it is so bad that they are unable to go about their everyday lives during that time. Various treatments and measures can help to relieve PMS.

MalaCards based summary: Premenstrual Tension, also known as premenstrual syndrome, is related to neurotic disorder and endogenous depression, and has symptoms including pelvic pain, pain and other symptoms associated with female genital organs and mittelschmerz. An important gene associated with Premenstrual Tension is GNRH1 (Gonadotropin Releasing Hormone 1), and among its related pathways/superpathways are Prader-Willi and Angelman syndrome and Antipsychotics Pathway (Metabolic Side Effects), Pharmacodynamics. The drugs Naproxen and Fluoxetine have been mentioned in the context of this disorder. Affiliated tissues include breast, skin and brain.

Wikipedia: 75 Premenstrual syndrome (PMS) refers to emotional and physical symptoms that regularly occur in the one to... more...

Related Diseases for Premenstrual Tension

Diseases related to Premenstrual Tension via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 245)
# Related Disease Score Top Affiliating Genes
1 neurotic disorder 30.1 POMC LIPN
2 endogenous depression 30.1 POMC GNRH1
3 migraine with or without aura 1 30.1 REN POMC MTRNR2L5 LIPN
4 sleep disorder 30.0 REN POMC
5 hyperprolactinemia 29.8 POMC GNRH1
6 estrogen excess 29.7 PGR GNRH1
7 vaginal discharge 29.7 PGR GNRH1
8 hypothyroidism 29.6 REN POMC GNRH1
9 conn's syndrome 29.6 REN POMC GNRH1
10 leiomyoma, uterine 29.4 PGR GNRH1
11 ovarian disease 29.2 POMC PGR GNRH1
12 premature menopause 29.0 REN POMC PGR GNRH1
13 placental site trophoblastic tumor 10.5
14 mood disorder 10.5
15 rickets 10.4
16 anxiety 10.4
17 postpartum depression 10.3
18 keratomalacia 10.3
19 panic disorder 10.2
20 acne 10.2
21 psychotic disorder 10.2
22 spondylometaphyseal dysplasia, sedaghatian type 10.2
23 leptin deficiency or dysfunction 10.2
24 hypothalamic disease 10.2 POMC GNRH1
25 bell's palsy 10.2 MTRNR2L5 LIPN
26 pituitary apoplexy 10.2 POMC GNRH1
27 van maldergem syndrome 1 10.2 POMC GNRH1
28 17-beta hydroxysteroid dehydrogenase iii deficiency 10.1 POMC GNRH1
29 empty sella syndrome 10.1 POMC GNRH1
30 central precocious puberty 10.1 POMC GNRH1
31 precocious puberty, male-limited 10.1 POMC GNRH1
32 facial nerve disease 10.1 MTRNR2L5 LIPN
33 central diabetes insipidus 10.1 POMC GNRH1
34 facial paralysis 10.1 MTRNR2L5 LIPN
35 adrenal hypoplasia, congenital 10.1 POMC GNRH1
36 pituitary hormone deficiency, combined, 2 10.1 POMC GNRH1
37 obsessive-compulsive disorder 10.1
38 generalized anxiety disorder 10.1
39 disease of mental health 10.1
40 breast disease 10.1
41 severe combined immunodeficiency 10.1
42 irritable bowel syndrome 10.1
43 hypoglycemia 10.1
44 sebaceous gland disease 10.1 POMC GNRH1
45 alcohol dependence 10.1
46 hypothyroidism, congenital, nongoitrous, 1 10.1
47 bulimia nervosa 10.1
48 eclampsia 10.1
49 pain agnosia 10.1 POMC LIPN
50 agnosia 10.1 POMC LIPN

Graphical network of the top 20 diseases related to Premenstrual Tension:



Diseases related to Premenstrual Tension

Symptoms & Phenotypes for Premenstrual Tension

UMLS symptoms related to Premenstrual Tension:


pelvic pain; pain and other symptoms associated with female genital organs; mittelschmerz; unspecified symptom associated with female genital organs; other specified symptoms associated with female genital organs; female genital pain and other symptoms

Drugs & Therapeutics for Premenstrual Tension

PubMed Health treatment related to Premenstrual Tension: 63

There isn’t much good research on what can help reduce PMS. So it isn’t clear how effective many of the PMS treatments are. Girls and women with PMS often try out different things to reduce their symptoms. For instance, some women with mild PMS try out relaxation techniques, acupuncture , getting more exercise , drinking less alcohol and coffee, or eating less salt. Others use herbal products and dietary supplements such as chaste tree extracts (Vitex agnus castus), St. John’s wort, calcium or pyridoxine vitamin B6 ). More severe PMS can be treated with a number of medications. But many of these medications haven’t been approved for the treatment of PMS, and they can have side effects: Hormone medications like the birth control pill or hormone patches affect women’s hormone levels and lead to an improvement in PMS or PMDD. Antidepressants : SSRIs (selective serotonin reuptake inhibitors ) can help reduce severe psychological problems caused by PMS or PMDD. Painkillers can effectively relieve severe period pain and are usually well tolerated. There is very little research on whether they also help in PMS, though. Women who have problems with PMS-related water retention can take diuretics (water pills ) . If PMS causes psychological problems, cognitive behavioral therapy (CBT) is an option. But it isn’t clear whether it helps in PMS.

Drugs for Premenstrual Tension (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 111)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Naproxen Approved, Vet_approved Phase 4 22204-53-1 156391 1302
2
Fluoxetine Approved, Vet_approved Phase 4 54910-89-3 3386
3
Ethinylestradiol Approved Phase 4 57-63-6 5991
4
Drospirenone Approved Phase 4 67392-87-4 68873
5
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
6
Polyestradiol phosphate Approved Phase 4 28014-46-2
7
Sertraline Approved Phase 4 79617-96-2 68617
8
Hydrocortisone succinate Approved Phase 4 2203-97-6 3643
9
Hydrocortisone acetate Approved, Vet_approved Phase 4 50-03-3
10
Hydrocortisone Approved, Vet_approved Phase 4 50-23-7 3640 5754
11
Paroxetine Approved, Investigational Phase 4 61869-08-7 43815
12
Flutamide Approved, Investigational Phase 4 13311-84-7 3397
13
Desogestrel Approved Phase 4 54024-22-5 40973
14
Dinoprostone Approved Phase 4 363-24-6, 7448-03-5 5280360
15
Epoprostenol Approved Phase 4 61849-14-7, 35121-78-9 5282411
16
Sumatriptan Approved, Investigational Phase 4 103628-46-2 5358
17
Salmon calcitonin Approved, Investigational Phase 4 47931-85-1 155817456
18
Citalopram Approved Phase 4 59729-32-7, 59729-33-8 2771
19
Calcitonin gene-related peptide Investigational Phase 4 83652-28-2 91976570
20
Tezosentan Investigational Phase 4 180384-57-0
21
Dexetimide Withdrawn Phase 4 21888-98-2 30843
22 Analgesics Phase 4
23 Antirheumatic Agents Phase 4
24 Cyclooxygenase Inhibitors Phase 4
25 Contraceptives, Oral Phase 4
26 Contraceptive Agents Phase 4
27 Anti-Inflammatory Agents, Non-Steroidal Phase 4
28 Analgesics, Non-Narcotic Phase 4
29 Anti-Inflammatory Agents Phase 4
30 Drospirenone and ethinyl estradiol combination Phase 4
31 Contraceptives, Oral, Combined Phase 4
32 Cytochrome P-450 Enzyme Inhibitors Phase 4
33 Estrogens Phase 4
34 Estradiol 3-benzoate Phase 4
35 Estradiol 17 beta-cypionate Phase 4
36 Hormones Phase 4
37 Hormone Antagonists Phase 4
38 Progestins Phase 4
39 Antineoplastic Agents, Hormonal Phase 4
40 Contraceptives, Oral, Hormonal Phase 4
41 Hydrocortisone 17-butyrate 21-propionate Phase 4
42 Diuretics, Potassium Sparing Phase 4
43 diuretics Phase 4
44 Mineralocorticoids Phase 4
45 Mineralocorticoid Receptor Antagonists Phase 4
46 Neurosteroids Phase 4
47 Androgens Phase 4
48 Androgen Antagonists Phase 4
49 Dacuronium Phase 4
50 Serotonin Receptor Agonists Phase 4

Interventional clinical trials:

(show top 50) (show all 83)
# Name Status NCT ID Phase Drugs
1 Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives. Unknown status NCT01251263 Phase 4 Estradiol or Placebo
2 A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine When Used for the Treatment of Premenstrual Dysphoria Completed NCT00516113 Phase 4 paroxetine
3 The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder Completed NCT00678574 Phase 4 fluoxetine
4 Androgen Hormones in PMDD Completed NCT00611923 Phase 4 Flutamide;Placebo
5 Short-Term Versus Long-Term Treatment for Severe PMS Completed NCT00318773 Phase 4 sertraline
6 A Comparative Efficacy of Low-dose Combine Oral Contraceptives Containing Desogestrel 150 mg and Drospirenone 3 mg on Premenstrual Symptoms Completed NCT01482338 Phase 4 EE 20 microgram with desogestrel 150 mg;EE 20 microgram with drospirenone 3 mg
7 Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment)Of Menstrual Migraine Completed NCT00904098 Phase 4 Frovatriptan;Usual Care
8 Evaluation of CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Saliva of Menstrual Migraine Patients Before and After Treatment With Treximet™ Completed NCT01329562 Phase 4 Treximet;Placebo
9 An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine Completed NCT01578941 Phase 4
10 Escitalopram for Premenstrual Syndrome (PMS) in Teens: A Pilot Study Terminated NCT00523705 Phase 4 escitalopram
11 EnBrace HR for Premenstrual Syndrome (PMS) With Prominent Mood Symptoms (or Menstrual Related Mood Disorders, MRMD) Withdrawn NCT04123483 Phase 4 EnBrace HR Softgel
12 Does Adding Combined Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome? A Double Blind Placebo Controlled Study. Unknown status NCT02562053 Phase 3 Fluoxetine;Combined oral contraceptives;Placebo 1;Placebo 2
13 The Synergistic Use of Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in the Management of Severe Premenstrual Syndrome: A Randomized Double Blind Placebo Controlled Trial Unknown status NCT02488538 Phase 3 Combined oral contraceptives;Fluoxetine;Combined oral contraceptives placebo;Fluoxetine placebo
14 Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome: A Randomized Double Blind Placebo Controlled Trial Unknown status NCT02427334 Phase 3 Dienogest;Fluoxetine;Placebo
15 Is Homeopathic Treatment a Placebo Treatment? - Homeopathic Treatment of Premenstrual Syndrome- A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial Unknown status NCT02402049 Phase 3 Natrum muriaticum 30C;Lachesis 30C;Sepia 30C;Nux vomica 30C;Pulsatilla 30C;Folliculinum 30C;Placebo Natrum muriaticum;Placebo Lachesis;Placebo Sepia;Placebo Nux vomica;Placebo pulsatilla;Placebo Folliculinum
16 Phase 3 Study Efficacy and Tolerance: The Use of 2 Phytomedicines in Association GAMALINE® 900mg + HIPERICIN® 300mg for the Treatment of Pre-Menstrual Syndrome (PMS) and Vasomotor Symptoms Unknown status NCT01365676 Phase 3 GAMALINE® + HIPERICIN®;GAMALINE®
17 Calcium Supplements Versus Oral Contraceptive Pills Containing Drospirenone in Treating Mild to Moderate Premenstrual Syndrome: A Double Blind Randomized Placebo Controlled Trial Completed NCT02089620 Phase 3 Yasmin;Placebo 1;Placebo 2
18 Double-blind Comparison of VAC BNO 1095 Film Coated Tablets With Placebo to Identify Dose Dependent Effects in Patients Suffering From Cyclic Mastodynia and Premenstrual Syndrome Completed NCT01309113 Phase 3 VAC BNO 1095 film coated tablets
19 The Impact of Sérélys PMS, a Herbal Remedy Based on Pollen Extraction and Saffron, on Symptoms of PMS: A Randomized, Double-blinded, Placebo Controlled Study Completed NCT03298607 Phase 3
20 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Levonorgestrel 90 Mcg and Ethinyl Estradiol 20 Mcg in a Continuous Daily Regimen on Menstrual Cycle-Related Symptoms Completed NCT00161681 Phase 3 Levonorgestrel/Ethinyl Estradiol
21 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of a Combination of Levonorgestrel and Ethinyl Estradiol in a Continuous Daily Regimen in Subjects With Premenstrual Dysphoric Disorder Completed NCT00128934 Phase 3 levonorgestrel/ethinyl estradiol
22 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of a Combination of Levonorgestrel and Ethinyl Estradiol in a Continuous Daily Regimen in Subjects With Premenstrual Dysphoric Disorder Completed NCT00195559 Phase 3 Levonorgestrel/Ethinyl Estradiol
23 Prospective, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Randomized Clinical Trial to Proof Efficacy and Safety of 20 mg (2 Tablets of 10 mg) VAC BNO 1095 FCT in Patients Suffering From Cyclic Mastodynia and PMS Terminated NCT01870687 Phase 3 20mg VAC BNO 1095 FCT;Placebo
24 Prospective, Controlled, Single-blinded, Longitudinal, Two-arms, Clinical Study Evaluation of Efficacy/Safety of EVE-PMS Skin-Test Panel -Detecting Sensitivity to Sex Hormones in Women With Premenstrual Syndrome Unknown status NCT00866437 Phase 2 Skin test panel
25 A Phase II Randomized, Two-arms, Single-blind, Cross Controlled Study for Evaluation the Safety and Efficacy of Diagnosis and Treatment of Premenstrual Syndrome by Detecting Skin Reactions Followed by Desensitization to Sex Hormones Unknown status NCT00873262 Phase 2 Skin test panel and desensitization kit;Skin test panel and solvent
26 a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS) Completed NCT00672607 Phase 2 extracts of Vitex agnus castus tablets;Placebo
27 The Effect of Individualised Homoeopathic Treatment Using the Grant Bentley Method in Premenstrual Syndrome Completed NCT02481973 Phase 2
28 Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder Completed NCT00048854 Phase 1, Phase 2 Sertraline
29 An Observational Study on the Efficacy of Individualised Homoeopathic Treatment on Premenstrual Syndrome in Indian Females Completed NCT02467088 Phase 2
30 Auriculotherapy in the Cares to the Premenstrual Syndrome: Randomized Clinical Trial Completed NCT01782040 Phase 2
31 An Exploratory Phase II, Randomised, Double-blind, Placebo-controlled, Parallel-group Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine Completed NCT04102995 Phase 2 Sepranolone injection low dose;Sepranolone injection high dose;Placebo injection
32 The Treatment of Menstrually-Related Mood Disorders With Extended Versus Interrupted Oral Contraceptives Terminated NCT00089414 Phase 2 Ethinyl Estradiol/Drospirenone;Placebo;CDB 2914
33 The Effects of Dutasteride on Mood, HPA Axis, and Serum Allopregnanolone Levels in Women With Menstrual-Related Mood Disorders and Controls Completed NCT00082043 Phase 1 Dutasteride;Placebo oral capsule
34 The Treatment of Menstrually-Related Mood Disorders With the Gonadotropin Releasing Hormone (GnRH) Agonist, Depot Leuprolide Acetate (Lupron) Completed NCT00001259 Phase 1 Leuprolide;Estradiol Patches;Progesterone
35 Evaluation of the Effect of Different Acupuncture Dose on Premenstrual Syndrome and the Relationship Between Premenstrual Syndrome and TCM Syndrome Complex Unknown status NCT04296422 NSAIDs or oral contraceptives treatment
36 The Study of Efficacy and Effect of Different Dose Acupuncture on Autonomic Nervous Activity and Quality of Life in Women With Dysmenorrhea Unknown status NCT03881319 Conventional gynecologic treatment
37 The Symptom Experience of Women With Perimenstrual Syndrome;Women's Health Related Quality of Life. Unknown status NCT00174161
38 Comparison of the Prophylactic Effect Between Acupuncture and Acupressure on Menstrual Migraine Unknown status NCT02592681
39 Detecting Auricular Points Among Patients With Menstrual Migraine by A Novel Auricular Point Detector (APD): A Pilot Diagnostic Accuracy Study Unknown status NCT03702114
40 Evaluating Treatment With Homeopathy, Acupuncture, and Anthroposophic Medicine in Improving the Quality of Life for Women Treated at the Public Unified Healthcare System Unknown status NCT02504515
41 Foot Reflexology Combined With Dietary Modification on Premenstrual Syndrome Completed NCT04348201
42 Development and Evaluation of an Internet-based Cognitive Behaviour Therapy for Women With Premenstrual Syndrome (PMS) Completed NCT01961479
43 Effects of Aerobic Exercise on the Symptoms of Premenstrual Syndrome and Dysmenorrhoea and Blood Flow of Genital Tract: A Prospective Interventional Study Completed NCT04618172
44 Effect of Aeropbic Exercise as Swimming on Premenstrual Syndrome Completed NCT03264612
45 Study to Evaluate the Efficacy of Your Super's Moon Balance and Its Impact on Premenstrual Syndrome and Menstrual Symptoms Completed NCT05237661
46 Effect of Sufficient Dietary Calcium Intake in Women With Premenstrual Syndrome Completed NCT02809066
47 Effect of Whole-body Vibration Versus Aerobic Exercise on the Inflammatory Status and Hormonal Parameters in Females With Premenstrual Syndrome Completed NCT04855981
48 Physical Activity Level, Aerobic Capacity and Dietary Habits Among a Cohort of Females With Premenstrual Syndrome: an Observational Study Completed NCT04901598
49 Effect of Aerobic Exercise Training on Premenstrual Syndrome Symptoms and Health Related Quality of Life Among Working Women Completed NCT05349344
50 The Effect of Nutrition Education on Premenstrual Syndrome: Randomized Controlled Study Completed NCT05144568

Search NIH Clinical Center for Premenstrual Tension

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Ibuprofen
Mefenamic Acid
pamabrom
solufenum

Cochrane evidence based reviews: premenstrual syndrome

Genetic Tests for Premenstrual Tension

Anatomical Context for Premenstrual Tension

Organs/tissues related to Premenstrual Tension:

MalaCards : Breast, Skin, Brain, Liver, Pituitary, Thyroid, Amygdala

Publications for Premenstrual Tension

Articles related to Premenstrual Tension:

(show top 50) (show all 2895)
# Title Authors PMID Year
1
The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study. 53 62
10368798 1999
2
Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. 53 62
9230648 1997
3
Clinical applications of GnRH and its analogues. 53 62
18407075 1992
4
Antenatal depressive symptoms are strongly predicted by the severity of pre-menstrual syndrome: results of partial least squares analysis. 62
36415609 2023
5
Stress and rumination in Premenstrual Syndrome (PMS): Identifying stable and menstrual cycle-related differences in PMS symptom severity. 62
36162688 2022
6
Evaluation of the effectiveness of yoga in management of premenstrual syndrome: a systematic review and meta-analysis. 62
35697020 2022
7
Mifepristone blocks the anxiolytic- and antidepressant-like effects of allopregnanolone in male rats. 62
36469636 2022
8
Menstrual cycle and exogenous attention toward emotional expressions. 62
36116197 2022
9
Clinical correlates of women endorsing premenstrual suicidal ideation: a cross-sectional study. 62
36348456 2022
10
Effect of nitric oxide-cyclic GMP-K+ channels pathway blockers, naloxone and metformin on the antinociception induced by the diuretic pamabrom. 62
36318824 2022
11
Premenstrual syndrome is associated with an altered spontaneous electroencephalographic delta/beta power ratio across the menstrual cycle. 62
36029920 2022
12
Effects of curcumin-piperine supplementation on systemic immunity in young women with premenstrual syndrome and dysmenorrhea: A randomized clinical trial. 62
36174434 2022
13
The effect of peer education compared to education provided by healthcare providers on premenstrual syndrome in high school students: A social network-based quasi-experimental controlled trial. 62
36411265 2022
14
Menstrual cycle phase, menopausal transition stage, self-reports of premenstrual syndrome and symptom severity: observations from the Seattle Midlife Women's Health Study. 62
36194847 2022
15
Effects of SARS-CoV-2 infection and COVID-19 pandemic on menstrual health of women: A systematic review. 62
36248348 2022
16
Comorbidities in patients with migraine in Japan: a cross-sectional study using data from National Health and Wellness Survey. 62
36450434 2022
17
A Systematic Review and Meta-Analysis of Premenstrual Syndrome with Special Emphasis on Herbal Medicine and Nutritional Supplements. 62
36355543 2022
18
Premenstrual disorders: Premenstrual syndrome and premenstrual dysphoric disorder. 62
36317488 2022
19
Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studies. 62
35081993 2022
20
The effects of emotional freedom techniques on coping with premenstrual syndrome: A randomized control trial. 62
34610147 2022
21
Effect of internet-based counselling with a cognitive-behavioural approach on premenstrual syndrome. 62
36224664 2022
22
A global view on premenstrual syndrome. 62
36302900 2022
23
The effect of Dioscorea esculenta powder on prostaglandin E2 and cytochrome c oxidase subunit 2 levels, menstrual pain, and premenstrual syndrome in young women: A randomized double-blind controlled trial. 62
36217795 2022
24
The relationship between high physical activity and premenstrual syndrome in Japanese female college students. 62
36163183 2022
25
Patterns of premenstrual syndrome in collegiate women: A cross-sectional study. 62
36107511 2022
26
Unfolding the mystery of premenstrual syndrome (PMS): an overview. 62
36117244 2022
27
The neuropsychotropic effects of Crocus sativus L. (saffron): an overview of systematic reviews and meta-analyses investigating its clinical efficacy in psychiatric and neurological disorders. 62
36249453 2022
28
Environmental risk factors, protective factors, and biomarkers for postpartum depressive symptoms: an umbrella review. 62
35803397 2022
29
Women's Health Care Committee, Japan Society of Obstetrics and Gynecology: Annual report-2022. 62
35871599 2022
30
Personal motivation, self-regulation barriers and strategies for weight loss in people with overweight and obesity: a thematic framework analysis. 62
35190011 2022
31
Lifestyle and Prevalence of Menstrual Disorders among Undergraduate Medical and Nursing Students: Can We Bring a Change? 62
35928060 2022
32
Clinical pharmacology of progestins. 62
34180615 2022
33
The effects of obesity on the menstrual cycle. 62
35871162 2022
34
The prevalence of menstrual disorders and premenstrual syndrome among adolescent girls living in North Borneo, Malaysia: a questionnaire-based study. 62
35964024 2022
35
Relationship between fear of COVID-19 and premenstrual syndrome in Turkish university students. 62
35875861 2022
36
Premenstrual syndrome severity in Turkey: a meta-analysis study. 62
35903865 2022
37
Premenstrual Syndrome and Childbirth Fear Prior to Pregnancy in Young Women: An Association and Cross-Sectional Study. 62
35946765 2022
38
Relationship of premenstrual syndrome with postpartum depression and mother-infant bonding. 62
34231233 2022
39
Mood Swing during Menstruation: Confounding Factors and Drug Use. 62
35950064 2022
40
Amenorrhea, premenstrual tension syndrome, and dysmenorrhea among women of reproductive age on hemodialysis: A national study in Egypt. 62
35124847 2022
41
Traditional Medicinal Uses, Phytochemistry, Biological Properties, and Health Applications of Vitex sp. 62
35893648 2022
42
Acute mania following COVID-19 in a woman with no past psychiatric history case report. 62
35858846 2022
43
Can animal models resemble a premenstrual dysphoric condition? 62
35623450 2022
44
Premenstruális szindróma és premenstruális dysphoriás zavar. 62
35895486 2022
45
Premenstruális szindróma és premenstruális dysphoriás zavar. 62
35895550 2022
46
Evaluation of a natural S-equol supplement in treating premenstrual symptoms and the effect of the gut microbiota: An open-label pilot study. 62
35128842 2022
47
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target. 62
35815177 2022
48
Effect of omega-3 fatty acids on premenstrual syndrome: A systematic review and meta-analysis. 62
35266254 2022
49
The Effectiveness of Transdiagnostic Treatment Program on Clinical Symptoms and Emotion Regulation in Girls Adolescents with Premenstrual Syndrome. 62
36447966 2022
50
Effects of Auriculotherapy on treatment of women with premenstrual syndrome symptoms: A randomized, placebo-controlled clinical trial. 62
35167949 2022

Variations for Premenstrual Tension

Expression for Premenstrual Tension

Search GEO for disease gene expression data for Premenstrual Tension.

Pathways for Premenstrual Tension

Pathways related to Premenstrual Tension according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.73 POMC GNRH1
2 9.92 POMC ANKK1

GO Terms for Premenstrual Tension

Sources for Premenstrual Tension

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....